July 19 (Reuters) – Privately held Jounce Therapeutics Inc,
which is working on treatments designed to use a patients’ own
immune systems to better attack cancer, said on Tuesday it had
entered into…
The post Celgene to collaborate with tiny Jounce on cancer immunotherapy appeared first on NASDAQ.